New Zealand Clinical Research

Homepage: nzcr.co.nz

ROR: 01q7qpe08

OpenAlex ID: I4405259085

CRISPR-Cas9 In Vivo Gene Editing for Transthyretin Amyloidosis

2021 · Julian D. Gillmore, Ed Gane, et al. · New England Journal of Medicine · 1,839

PDF

Bivalent Prefusion F Vaccine in Pregnancy to Prevent RSV Illness in Infants

2023 · Beate Kampmann, Shabir A. Madhi, et al. · New England Journal of Medicine · 1,068

PDF

Sofosbuvir and Velpatasvir for HCV Genotype 2 and 3 Infection

2015 · Graham R. Foster, Nezam Afdhal, et al. · New England Journal of Medicine · 871

PDF

Feature Shrinkage Pyramid for Camouflaged Object Detection with Transformers

2023 · Zhou Huang, Hang Dai, et al. · IEEE Computer Society Conference on Computer Vision and Pattern Recognition/Proceedings - IEEE Computer Society Conference on Computer Vision and Pattern Recognition/Proceedings · 345

Oral combination therapy with a nucleoside polymerase inhibitor (RG7128) and danoprevir for chronic hepatitis C genotype 1 infection (INFORM-1): a randomised, double-blind, placebo-controlled, dose-escalation trial

2010 · Edward J Gane, Stuart K Roberts, et al. · The Lancet · 341

Improved Glycemic Outcomes With Medtronic MiniMed Advanced Hybrid Closed-Loop Delivery: Results From a Randomized Crossover Trial Comparing Automated Insulin Delivery With Predictive Low Glucose Suspend in People With Type 1 Diabetes

2021 · Olivia J. Collyns, Renee A. Meier, et al. · Diabetes Care · 293

PDF

Effect of renal impairment on the pharmacokinetics of the GLP‐1 analogue liraglutide

2009 · Lisbeth V. Jacobsen, Charlotte Hindsberger, et al. · British Journal of Clinical Pharmacology · 217

PDF

Pharmacokinetics and Pharmacodynamics of Intravenous and Subcutaneous Continuous Erythropoietin Receptor Activator (C.E.R.A.) in Patients with Chronic Kidney Disease

2006 · Iain C. Macdougall, Richard Robson, et al. · Clinical Journal of the American Society of Nephrology · 190

A seca e a crise hídrica de 2014-2015 em São Paulo

2015 · José A. Marengo, Carlos Afonso Nobre, et al. · Revista USP · 172

Bivalirudin pharmacokinetics and pharmacodynamics: Effect of renal function, dose, and gender

2002 · Richard Robson, Harvey White, et al. · Clinical Pharmacology & Therapeutics · 168

Effects of Renal Impairment on the Pharmacokinetics, Efficacy, and Safety of Inclisiran: An Analysis of the ORION-7 and ORION-1 Studies

2019 · R. Scott Wright, Michael G. Collins, et al. · Mayo Clinic Proceedings · 165

The Cathepsin K Inhibitor Odanacatib Suppresses Bone Resorption in Women With Breast Cancer and Established Bone Metastases: Results of a 4-Week, Double-Blind, Randomized, Controlled Trial

2010 · Anders Bonde Jensen, Christopher Wynne, et al. · Clinical Breast Cancer · 152

Comparison of Subcutaneous and Intravenous Administration of Trastuzumab: A Phase I/Ib Trial in Healthy Male Volunteers and Patients With HER2‐Positive Breast Cancer

2012 · Chris Wynne, Vernon Harvey, et al. · The Journal of Clinical Pharmacology · 128

Hydrofluoroalkane-134a Beclomethasone Dipropionate, 400 μg, Is as Effective as Chlorofluorocarbon Beclomethasone Dipropionate, 800 μg, for the Treatment of Moderate Asthma

1999 · Gary Gross, Philip J. Thompson, et al. · CHEST Journal · 124

Evaluation of RNAi therapeutics VIR-2218 and ALN-HBV for chronic hepatitis B: Results from randomized clinical trials

2023 · Ed Gane, Young-Suk Lim, et al. · Journal of Hepatology · 115

PDF

RNA interference targeting ANGPTL3 for triglyceride and cholesterol lowering: phase 1 basket trial cohorts

2023 · Gerald F. Watts, Christian Schwabe, et al. · Nature Medicine · 113

PDF

Robust antiviral activity of R1626, a novel nucleoside analog: A randomized, placebo‐controlled study in patients with chronic hepatitis C†

2008 · Stuart K. Roberts, Graham Cooksley, et al. · Hepatology · 112

A phase I/II study of ARO-HSD, an RNA interference therapeutic, for the treatment of non-alcoholic steatohepatitis

2022 · Lung-Yi Mak, Ed Gane, et al. · Journal of Hepatology · 101

Sofosbuvir Plus Velpatasvir Combination Therapy for Treatment-Experienced Patients With Genotype 1 or 3 Hepatitis C Virus Infection: A Randomized Trial

2015 · Stephen Pianko, Steven L. Flamm, et al. · Annals of Internal Medicine · 94

Effect of IL28B Genotype on Early Viral Kinetics During Interferon-Free Treatment of Patients With Chronic Hepatitis C

2012 · Tom W. Chu, Rohit Kulkarni, et al. · Gastroenterology · 94

PDF

Phase 1 Trial of CRISPR-Cas9 Gene Editing Targeting ANGPTL3

2025 · Luke J. Laffin, Stephen J. Nicholls, et al. · New England Journal of Medicine · 92

Long-term efficacy and safety of lerodalcibep in heterozygous familial hypercholesterolaemia: the LIBerate-HeFH trial

2023 · Frederick Raal, Nyda Fourie, et al. · European Heart Journal · 81

PDF

First‐in‐human phase 1 trial evaluating safety, pharmacokinetics, and pharmacodynamics of NLRP3 inflammasome inhibitor, GDC‐2394, in healthy volunteers

2023 · Fei Tang, Rebecca Kunder, et al. · Clinical and Translational Science · 77

PDF

Ecological impact of three pest management systems in New Zealand apple orchards

1999 · D.M Suckling, J.T.S Walker, et al. · Agriculture Ecosystems & Environment · 75

Improved technology satisfaction and sleep quality with Medtronic MiniMed® Advanced Hybrid Closed-Loop delivery compared to predictive low glucose suspend in people with Type 1 Diabetes in a randomized crossover trial

2021 · Benjamin J. Wheeler, Olivia J. Collyns, et al. · Acta Diabetologica · 70

Works count: 96

Works count with child and predecessor institutions: 181

Citation count: 5,892